Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
CN Stock MarketDetailed Quotes
Huaren Pharmaceutical (300110)
- 3.08
- -0.02-0.65%
Trading Apr 28 11:03 CST
3.64BMarket Cap-7.86P/E (TTM)
3.15High3.07Low157.96KlotVolume3.10Open3.10Prev Close49.05MTurnover1.34%Turnover RatioLossP/E (Static)1.18BShares3.7552wk High4.27P/B3.64BFloat Cap2.8252wk Low3.72Limit Up1.18BShs Float15.21Historical High2.48Limit Down2.58%Range %2.05Historical Low--Dividend TTM3.11Avg Price85.09KlotAsk--Div Yield TTM100Lot Size72.88KlotBid
Huaren Pharmaceutical (300110) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 1.93%185.49M | -15.16%138.97M | 85.59%222.89M | 84.31%211.06M | 62.25%181.98M | -29.40%163.81M | -40.02%120.1M | -67.20%114.51M | -50.47%112.16M | 4.66%232.04M |
| Notes receivable and accounts receivable | -5.40%508.45M | -6.97%493.02M | -12.11%513.74M | -15.18%519.51M | -19.13%537.47M | -19.26%529.96M | -10.03%584.56M | -8.33%612.48M | -2.35%664.63M | 2.75%656.37M |
| -Notes receivable | -12.71%8.97M | 150.14%8.88M | 571.90%6.65M | 376.79%6.69M | 618.98%10.28M | 116.69%3.55M | -52.78%989.06K | -6.90%1.4M | 0.44%1.43M | -21.35%1.64M |
| -Accounts receivable | -5.26%499.48M | -8.03%484.14M | -13.10%507.1M | -16.08%512.82M | -20.51%527.19M | -19.60%526.41M | -9.89%583.57M | -8.33%611.08M | -2.36%663.2M | 2.83%654.73M |
| Other receivables (including interest and dividends) | -36.09%28.78M | -39.51%20.99M | -97.29%37.07M | -97.44%35.09M | -96.72%45.03M | -97.46%34.71M | -2.53%1.37B | -3.37%1.37B | -4.30%1.37B | -4.52%1.36B |
| -Other receivable | ---- | -39.51%20.99M | ---- | -97.44%35.09M | ---- | -97.46%34.71M | ---- | -3.37%1.37B | ---- | -4.52%1.36B |
| Advance payment | 39.95%43.68M | -6.38%18.99M | -30.41%33.08M | -54.07%27.48M | -22.53%31.21M | -47.34%20.29M | -44.47%47.53M | -42.80%59.83M | -48.11%40.28M | -37.33%38.52M |
| Inventories | -12.70%245.72M | -24.11%241.51M | -18.71%252.56M | -12.54%279.06M | -11.82%281.48M | -4.90%318.24M | -9.24%310.69M | 7.18%319.07M | 30.97%319.19M | 25.40%334.63M |
| Receivable financing | 10.99%77.27M | -36.85%62.19M | -1.17%85.24M | -44.55%77.12M | -38.13%69.62M | -34.23%98.49M | -11.90%86.25M | 79.14%139.09M | 50.56%112.52M | 49.06%149.74M |
| Other current assets | -27.87%16.68M | -6.59%18.2M | -9.71%17.81M | 31.18%19.77M | 53.71%23.13M | 21.89%19.49M | -0.01%19.72M | -3.39%15.07M | 14.57%15.04M | 37.69%15.99M |
| Total current assets | -5.46%1.11B | -16.13%993.88M | -54.22%1.16B | -55.54%1.17B | -55.60%1.17B | -57.55%1.18B | -9.36%2.54B | -10.25%2.63B | -4.15%2.63B | 2.27%2.79B |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%15.98M | 0.00%15.98M | 0.00%15.98M | 0.00%15.98M | 0.00%15.98M | 0.00%15.98M | 0.00%15.98M | 0.00%15.98M | 0.00%15.98M | 0.00%15.98M |
| Other non-current financial assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment real estate | -3.19%8.74M | -3.17%8.81M | -3.14%8.88M | -3.12%8.96M | -3.09%9.03M | -3.07%9.1M | -3.05%9.17M | -3.02%9.24M | -3.00%9.32M | -2.98%9.39M |
| Fixed assets | ---- | -2.14%992.15M | ---- | -5.78%978.94M | ---- | -5.50%1.01B | ---- | -2.17%1.04B | ---- | -3.69%1.07B |
| Constru in process | ---- | 61.60%100.03M | ---- | 109.34%103.7M | ---- | 47.56%61.9M | ---- | 37.90%49.53M | ---- | 79.56%41.95M |
| Productive biological assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Oil and gas assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Intangible assets | -7.67%278.51M | -5.85%284.05M | -6.11%288.91M | -6.31%290.92M | -3.87%301.66M | -5.28%301.7M | -3.29%307.73M | -3.99%310.5M | -3.93%313.81M | -3.99%318.53M |
| Development expenditure | -43.99%3.45M | -45.10%3.25M | -67.80%2.81M | -46.82%6.19M | -54.24%6.16M | -54.57%5.92M | -61.14%8.73M | -33.79%11.65M | -15.41%13.46M | 3.94%13.04M |
| Goodwill | -71.62%207.89M | -71.62%207.89M | -10.66%732.61M | -10.66%732.61M | -10.66%732.61M | -10.66%732.61M | -0.76%820.04M | -0.76%820.04M | -0.76%820.04M | -0.76%820.04M |
| Long deferred expense | -41.18%5.47M | -46.98%6.47M | -30.07%9M | -13.17%9.92M | -31.24%9.3M | -23.99%12.2M | -18.65%12.87M | -6.98%11.43M | -2.91%13.52M | 9.96%16.05M |
| Deferred tax assets | 23.91%70.9M | 24.14%70.99M | 40.03%59.48M | 37.43%59.34M | 33.13%57.22M | 36.05%57.19M | -31.58%42.48M | -27.58%43.18M | -26.50%42.98M | -26.09%42.03M |
| Usufruct assets | 667.97%1.34M | 408.22%1.42M | 221.73%1.23M | -85.71%69.68K | -80.87%174.21K | -73.58%278.74K | -69.70%383.26K | -68.03%487.79K | -30.38%910.83K | -31.00%1.06M |
| Other non current assets | -58.66%20.65M | -47.25%17.08M | -3.36%36.78M | 28.94%49.25M | 23.17%49.96M | 38.69%32.38M | 65.30%38.06M | 70.77%38.2M | 57.84%40.56M | -12.38%23.34M |
| Total non current assets | -26.25%1.68B | -23.85%1.71B | -4.26%2.23B | -3.97%2.26B | -3.65%2.28B | -5.52%2.24B | -1.56%2.33B | -1.57%2.35B | -0.95%2.37B | -2.42%2.37B |
| Total assets | -19.20%2.79B | -21.18%2.7B | -30.29%3.4B | -31.21%3.42B | -31.02%3.45B | -33.64%3.43B | -5.78%4.87B | -6.35%4.98B | -2.66%5B | 0.06%5.17B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -10.59%437.2M | -22.14%330.42M | 15.68%485.93M | 20.92%503.02M | 7.86%488.97M | -32.08%424.41M | -36.97%420.06M | -52.56%415.99M | -55.21%453.34M | -48.72%624.83M |
| Notes payable and accounts payable | 47.45%179.74M | 35.66%199.9M | 1.19%115.5M | -21.96%120.22M | -7.77%121.9M | 3.54%147.35M | -9.72%114.14M | 8.25%154.05M | 5.55%132.17M | 15.94%142.32M |
| -Accounts payable | 47.45%179.74M | 35.66%199.9M | 1.19%115.5M | -21.96%120.22M | -7.77%121.9M | 3.54%147.35M | -9.72%114.14M | 8.25%154.05M | 5.55%132.17M | 15.94%142.32M |
| Contract liabilities | -0.79%29.5M | 3.83%33.71M | -9.90%33.12M | -7.58%32.68M | -25.94%29.74M | -41.56%32.46M | 57.96%36.76M | 9.38%35.36M | 27.16%40.16M | 73.61%55.55M |
| Advance receipts | --1.69M | --1.69M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Salaries payable | -29.03%15.08M | -9.08%15.51M | 10.67%17.35M | 10.61%16.56M | 25.42%21.24M | -25.80%17.06M | -14.75%15.67M | -26.22%14.97M | 19.55%16.94M | 82.32%22.99M |
| Taxs payable | 38.99%30.63M | 0.02%21.21M | -12.58%15.87M | -43.20%12.01M | 0.05%22.03M | -34.54%21.2M | -58.69%18.16M | -22.98%21.14M | -54.16%22.02M | -58.53%32.39M |
| Other payable (including interest and dividends) | 24.23%261.51M | 12.96%235.23M | 42.54%299.1M | 20.63%283.26M | -10.18%210.51M | -2.02%208.24M | -17.45%209.84M | -15.31%234.83M | 11.47%234.37M | 1.15%212.54M |
| -Other payable | ---- | 12.96%235.23M | ---- | 20.63%283.26M | ---- | -2.02%208.24M | ---- | -6.99%234.83M | ---- | 1.15%212.54M |
| Non current liabilities due within one year | -46.37%389.29M | -8.53%633.86M | -2.19%591.49M | -3.24%613.25M | 15.83%725.89M | 64.99%692.95M | -0.45%604.73M | 10.90%633.77M | 70.58%626.69M | 19.57%420M |
| Other current liabilities | 4.90%4.06M | 1.53%3M | -9.90%4.31M | -35.60%2.96M | -25.94%3.87M | -47.80%2.95M | 57.96%4.78M | 9.38%4.6M | 27.16%5.22M | 35.29%5.65M |
| Total current liabilities | -16.96%1.35B | -4.66%1.47B | 9.73%1.56B | 4.57%1.58B | 6.09%1.62B | 2.00%1.55B | -18.30%1.42B | -22.41%1.51B | -15.56%1.53B | -25.29%1.52B |
| Current liabilities | ||||||||||
| Long term loan | 18.15%464.13M | -41.77%270.22M | -35.39%366.13M | -36.24%385.95M | -35.16%392.83M | -44.52%464.08M | -14.90%566.68M | -7.90%605.34M | 20.12%605.86M | 137.12%836.42M |
| Long term salaries pay | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Deferred tax liabilities | -7.03%39.59M | -6.90%40.36M | -7.59%41.06M | -7.47%41.83M | -7.34%42.59M | -7.22%43.35M | -7.59%44.44M | -6.16%45.2M | -7.56%45.96M | -8.27%46.72M |
| Long term deferred income | 6,199.05%8.29M | 5,258.15%7.05M | -25.00%131.56K | -25.00%131.56K | -25.00%131.56K | -25.00%131.56K | -20.00%175.41K | -20.00%175.41K | -20.00%175.41K | -75.67%175.41K |
| Lease liabilities | --1.1M | --785.97K | --961.93K | ---- | ---- | ---- | --0 | --0 | -63.65%145.93K | -60.20%163.08K |
| Total non current liabilities | 17.81%513.11M | -37.27%318.41M | -33.21%408.29M | -34.24%427.9M | -33.21%435.54M | -42.55%507.56M | -14.56%611.29M | -8.03%650.72M | -4.60%652.14M | 65.55%883.48M |
| Total liabilities | -9.61%1.86B | -12.72%1.79B | -3.17%1.97B | -7.09%2.01B | -5.65%2.06B | -14.40%2.05B | -17.21%2.04B | -18.58%2.17B | -12.56%2.18B | -6.37%2.4B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.18B | 0.00%1.18B | 0.00%1.18B | 0.00%1.18B | 0.00%1.18B | 0.00%1.18B | 0.00%1.18B | 0.00%1.18B | 0.00%1.18B | 0.00%1.18B |
| Capital reserve funds | 0.00%528.04M | 0.00%528.04M | 0.00%528.04M | 0.00%528.04M | 0.00%528.04M | 0.00%528.04M | 0.00%528.04M | 0.00%528.04M | 0.00%528.04M | 0.00%528.04M |
| Surplus reserve funds | 0.00%90.53M | 0.00%90.53M | 7.09%90.62M | 6.99%90.53M | 6.99%90.53M | 6.99%90.53M | 9.75%84.62M | 9.75%84.62M | 9.75%84.62M | 9.74%84.62M |
| Retained profit | -95.66%-946.94M | -92.58%-962.9M | -145.93%-445.51M | -148.82%-462.67M | -150.94%-483.97M | -155.60%-500M | 13.34%969.92M | 18.31%947.6M | 21.08%950.04M | 20.95%899.22M |
| Shareholders equity without minority interests | -35.16%853.84M | -35.59%837.89M | -50.98%1.36B | -51.21%1.34B | -52.03%1.32B | -51.72%1.3B | 4.60%2.76B | 5.96%2.74B | 6.72%2.74B | 6.45%2.69B |
| Minority interests | -2.23%72.02M | -2.69%71.17M | -2.70%70.48M | 5.60%74.97M | 0.33%73.66M | 1.78%73.14M | 3.38%72.44M | 3.41%71M | 5.41%73.42M | 4.33%71.86M |
| Total shareholder equity | -33.41%925.86M | -33.83%909.06M | -49.75%1.43B | -49.77%1.41B | -50.66%1.39B | -50.33%1.37B | 4.57%2.84B | 5.89%2.81B | 6.69%2.82B | 6.39%2.77B |
| Total liabilityies and equity | -19.20%2.79B | -21.18%2.7B | -30.29%3.4B | -31.21%3.42B | -31.02%3.45B | -33.64%3.43B | -5.78%4.87B | -6.35%4.98B | -2.66%5B | 0.06%5.17B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Zhongxinghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongxinghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongxinghua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm